JONATHAN ROZACK: Open Payments
NPI 1255429288 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 54 payments from 19 companies in 2025. Trend: 2023 $404 · 2024 $636 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $187 |
| Viatris Specialty LLC | 3 | $82 |
| ABBVIE INC. | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 6 | $78 |
| Novo Nordisk Inc | 4 | $75 |
| Lilly USA, LLC | 5 | $73 |
| Insulet Corporation | 2 | $73 |
| Corcept Therapeutics | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
Products named: FANAPT, YUPELRI, VOQUEZNA, MOUNJARO, Omnipod, QULIPTA, Korlym, Cala kIQ.
Industry payments across ID — which companies pay providers there.
